All‐cause mortality · people with acute UGIH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visualisation of gastric mucosa · people with acute UGIH
It is very uncertain whether erythromycin plus nasogastric tube lavage changes visualisation of gastric mucosa compared with metoclopramide plus nasogastric tube lavage (very low certainty).
1 finding from 1 review
NSAEs · people with acute UGIH
1 finding from 1 review
Rebleeding · people with acute UGIH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood transfusion · people with acute UGIH
1 finding from 1 review
UGIH‐related mortality · people with acute UGIH
1 finding from 1 review
SAEs · people with acute UGIH
1 finding from 1 review
Mortality by end of study · Older people undergoing hip fracture aftercare
It is very uncertain whether multinutrient supplements (nasogastric) changes mortality by end of study compared with control (very low certainty).
1 finding from 1 review
Participants with complications (e.g. pressure sore, aspiration pneumonia) at end of study · Older people undergoing hip fracture aftercare
It is very uncertain whether multinutrient supplements (nasogastric) changes participants with complications (e.g. pressure sore, aspiration… compared with control (very low certainty).
1 finding from 1 review
Disability (unfavourable outcomes: death, vegetative state, severe disability; GOS 1‐3) at end of scheduled · Older people undergoing hip fracture aftercare
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Putative side effects of treatment (e.g. aspiration pneumonia) · Older people undergoing hip fracture aftercare
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Normalcy of diet (supplemental nutrition: TPN, PEG, nasogastric tube or IV hydration) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in normalcy of diet (supplemental nutrition: TPN, PEG, nasogastric tube… compared with placebo; GRADE not reported.
1 finding from 1 review
Age at full enteral feedings (days) · preterm infants less than 1500 grams
1 finding from 1 review
Feeding intolerance: number of days of feeding interruptions · preterm infants less than 1500 grams
1 finding from 1 review
Days to regain birth weight · preterm infants less than 1500 grams
1 finding from 1 review
Rate of weight gain (g/kg/day) · preterm infants less than 1500 grams
1 finding from 1 review
End of intervention: rate of gain in length (cm/week) · preterm infants less than 1500 grams
1 finding from 1 review
Growth: head circumference (cm/week) · preterm infants less than 1500 grams
1 finding from 1 review
Necrotising enterocolitis · preterm infants less than 1500 grams
Continuous showed no clear difference in necrotising enterocolitis (NEC) compared with intermittent bolus (nasogastric and orogastric tube) milk feeding ‐… (low certainty).
1 finding from 1 review
Treatment failure Feeding interruption, blocking or leakage of the tube, non‐adherence · adult patients with swallowing disturbances
Percutaneous endoscopic gastrostomy may leads to lower treatment failure Feeding interruption, blocking or leakage of the… compared with nasogastric tube feeding (low certainty).
1 finding from 1 review